EGFR and cancer: Therefore, in light of CD73’s role in cancer cell survival and progression, it would be insightful to explore whether inhibiting CD73 in combination with the EGFR inhibitor tyrphostin AG1478 could enhance therapeutic responses in a GB in vitro model.